at Nasdaq.com (Dec 1, 2014)
Solazyme (SZYM) closes on its $125M private offering of 6% Convertible Senior Subordinated Notes maturing in 2018, including $10M worth that was purchased by book-runner Goldman Sachs to cover over-allotments. SZYM received about $119.4M in net proceeds, and plans to use proceeds to to fund project-related costs as well as for capital expenditures and general purposes.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at MarketWatch.com (Apr 1, 2014)
at CNBC.com (Mar 25, 2014)
at CNBC.com (Mar 7, 2014)
at MarketWatch.com (Feb 27, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs